Provided by Tiger Trade Technology Pte. Ltd.

Moleculin Biotech

0.6447
-0.0052-0.80%
Post-market: 0.64580.0011+0.16%19:51 EDT
Volume:301.03K
Turnover:195.30K
Market Cap:12.56M
PE:-0.07
High:0.6720
Open:0.6400
Low:0.6200
Close:0.6499
52wk High:15.75
52wk Low:0.1614
Shares:19.48M
Float Shares:17.03M
Volume Ratio:0.39
T/O Rate:1.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.5973
EPS(LYR):-28.4188
ROE:-1371.64%
ROA:-84.57%
PB:1.08
PE(LYR):-0.02

Loading ...

Apr 18, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 17, 2025

Major Issues Report

Form 8-K - Current report
Apr 09, 2025

Major Issues Report

Form 8-K - Current report
Apr 04, 2025

Correspondence

Form CORRESP - Correspondence
Apr 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 31, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 24, 2025

Major Issues Report

Form 8-K - Current report
Mar 24, 2025

Major Issues Report

Form 8-K - Current report
Mar 21, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 06, 2025

Major Issues Report

Form 8-K - Current report
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Feb 13, 2025

Major Issues Report

Form 8-K - Current report
Feb 13, 2025

Major Issues Report

Form 8-K - Current report
Feb 11, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 11, 2025

Major Issues Report

Form 8-K - Current report
Feb 10, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 10, 2025

Major Issues Report

Form 8-K - Current report
Jan 29, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 27, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jan 27, 2025

Major Issues Report

Form 8-K - Current report